We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clearstream | LSE:CTN | London | Ordinary Share | IE00B03QHM52 | ORD EUR0.125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCTN
ClearStream Technologies Group PLC
07 April 2011
For Immediate Release 7 April 2011
ClearStream Technologies Group plc ("ClearStream" or "the Company")
Professor Patrick Prendergast elected as Provost of Trinity College Dublin
ClearStream is pleased to announce that Professor Patrick Prendergast, a non-Executive director of the Company, has been recently elected Provost of Trinity College Dublin (TCD), one of the most prestigious and influential positions across all of the Universities of Ireland.
Professor Prendergast (44) is Professor of Bio-engineering at TCD. He obtained a BAI in 1987 and a PhD in 1991 both from the University of Dublin. Before joining the staff at Trinity College, Dublin, Professor Prendergast held post-doctoral positions at the Istituti Ortopedici Rizzoli, Bologna, Italy, and the University of Nijmegen, The Netherlands. In November 2009, he was conferred with the degree of Sc.D.
A Chartered Engineer and a Fellow of the Institution of Engineers of Ireland, Professor Prendergast is an award winning researcher and has published 127 papers in peer-reviewed journals and 19 peer-reviewed book chapters. He has also contributed to several well-known reference texts in biomedical engineering.
Commenting on the appointment, Andrew Jones, CEO of ClearStream said: "I am delighted that Professor Prendergast has been elected to the prestigious role of Provost of TCD and that he has confirmed his desire to remain on ClearStream's Board.
"His appointment complements ClearStream's announcement earlier this week of the completion of a successful share placing which has raised approximately GBP1.9million of new equity capital for the Company. Professor Prendergast's breadth of experience and acknowledged expertise in the field of bio-engineering will be invaluable in helping the Board to critically evaluate new technology proposals. ".
For further information please Tel: + 353 (0) 53 923 contact: 7111 ClearStream Technologies Group plc Andrew Jones, CEO Winningtons Financial Tel: + 44 (0) 117 985 8989 Paul Vann Mob:+ 44 (0) 7768 807631 FinnCap Tel: + 44 (0) 20 7600 1658 Marc Young, Corporate Finance Charlotte Stranner, Corporate Finance Simon Starr, Corporate Broking
About ClearStream:
ClearStream, , based in Enniscorthy, Co Wexford, Ireland, is an innovative maker of medical devices used in peripheral (lower limb) and coronary interventional procedures, including catheters and stents. Its products are sold under ClearStream's own brands and are also supplied to Original Equipment Manufacturers.
The Company is listed on the AIM market of the London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAZQLFBFZFBBBV
1 Year Clearstream Chart |
1 Month Clearstream Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions